|
1
|
O’Shea RS, Dasarathy S, McCullough AJ, et
al; Practice Guideline Committee of the American Association for
the Study of Liver Diseases; Practice Parameters Committee of the
American College of Gastroenterology. Alcoholic liver disease.
Hepatology. 51:307–328. 2010.
|
|
2
|
Gao B and Bataller R: Alcoholic liver
disease: pathogenesis and new therapeutic targets.
Gastroenterology. 141:1572–1585. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li YM, Fan JG, Wang BY, et al: Guidelines
for the diagnosis and management of alcoholic liver disease: update
2010: (published in Chinese on Chinese Journal of Hepatology 2010;
18: 167–170). J Dig Dis. 12:45–50. 2011.PubMed/NCBI
|
|
4
|
Krol J and Krzyzosiak WJ: Structural
aspects of microRNA biogenesis. IUBMB Life. 56:95–100. 2004.
View Article : Google Scholar
|
|
5
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tang Y, Banan A, Forsyth CB, et al: Effect
of alcohol on miR-212 expression in intestinal epithelial cells and
its potential role in alcoholic liver disease. Alcohol Clin Exp
Res. 32:355–364. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yin H, Hu M, Zhang R, Shen Z, Flatow L and
You M: MicroRNA-217 promotes ethanol-induced fat accumulation in
hepatocytes by down-regulating SIRT1. J Biol Chem. 287:9817–9826.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Meng F, Glaser SS, Francis H, et al:
Epigenetic regulation of miR-34a expression in alcoholic liver
injury. Am J Pathol. 181:804–817. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bala S and Szabo G: MicroRNA Signature in
Alcoholic Liver Disease. Int J Hepatol. 2012:4982322012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu Y, Chen SH, Jin X and Li YM: Analysis
of differentially expressed genes and microRNAs in alcoholic liver
disease. Int J Mol Med. 31:547–554. 2013.PubMed/NCBI
|
|
11
|
Dippold RP, Vadigepalli R, Gonye GE, Patra
B and Hoek JB: Chronic ethanol feeding alters miRNA expression
dynamics during liver regeneration. Alcohol Clin Exp Res. 37(Suppl
1): E59–E69. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Castro RE, Ferreira DM, Zhang X, et al:
Identification of microRNAs during rat liver regeneration after
partial hepatectomy and modulation by ursodeoxycholic acid. Am J
Physiol Gastrointest Liver Physiol. 299:G887–G897. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dolganiuc A, Petrasek J, Kodys K, et al:
MicroRNA expression profile in Lieber-DeCarli diet-induced
alcoholic and methionine choline deficient diet-induced
nonalcoholic steatohepatitis models in mice. Alcohol Clin Exp Res.
33:1704–1710. 2009. View Article : Google Scholar
|
|
14
|
Zhang XG, Xu P, Liu Q, et al: Effect of
tea polyphenol on cytokine gene expression in rats with alcoholic
liver disease. Hepatobiliary Pancreat Dis Int. 5:268–272.
2006.PubMed/NCBI
|
|
15
|
Jin X, Ye YF, Chen SH, Yu CH, Liu J and Li
YM: MicroRNA expression pattern in different stages of nonalcoholic
fatty liver disease. Dig Liver Dis. 41:289–297. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Griffiths-Jones S: The microRNA Registry.
Nucleic Acids Res. 32:D109–D111. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Olson NE: The microarray data analysis
process: from raw data to biological significance. NeuroRx.
3:373–383. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tibshirani R, Hastie T, Narasimhan B and
Chu G: Diagnosis of multiple cancer types by shrunken centroids of
gene expression. Proc Natl Acad Sci USA. 99:6567–6572. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Eisen MB, Spellman PT, Brown PO and
Botstein D: Cluster analysis and display of genome-wide expression
patterns. Proc Natl Acad Sci USA. 95:14863–14868. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Masotti A and Alisi A: Integrated
bioinformatics analysis of microRNA expression profiles for an
in-depth understanding of pathogenic mechanisms in non-alcoholic
fatty liver disease. J Gastroenterol Hepatol. 27:187–188. 2012.
View Article : Google Scholar
|
|
21
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar
|
|
23
|
Krek A, Grün D, Poy MN, et al:
Combinatorial microRNA target predictions. Nat Genet. 37:495–500.
2005. View
Article : Google Scholar
|
|
24
|
Jin X, Chen YP, Kong M, Zheng L, Yang YD
and Li YM: Transition from hepatic steatosis to steatohepatitis:
unique microRNA patterns and potential downstream functions and
pathways. J Gastroenterol Hepatol. 27:331–340. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tsai KW, Wu CW, Hu LY, et al: Epigenetic
regulation of miR-34b and miR-129 expression in gastric cancer. Int
J Cancer. 129:2600–2610. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Brest P, Lassalle S, Hofman V, et al:
MiR-129-5p is required for histone deacetylase inhibitor-induced
cell death in thyroid cancer cells. Endocr Relat Cancer.
18:711–719. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dyrskjøt L, Ostenfeld MS, Bramsen JB, et
al: Genomic profiling of microRNAs in bladder cancer: miR-129 is
associated with poor outcome and promotes cell death in vitro.
Cancer Res. 69:4851–4860. 2009.PubMed/NCBI
|
|
28
|
Wang J, He Q, Han C, et al:
p53-Facilitated miR-199a-3p regulates somatic cell reprogramming.
Stem Cells. 30:1405–1413. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shatseva T, Lee DY, Deng Z and Yang BB:
MicroRNA miR-199a-3p regulates cell proliferation and survival by
targeting caveolin-2. J Cell Sci. 124:2826–2836. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pogribny IP, Starlard-Davenport A,
Tryndyak VP, et al: Difference in expression of hepatic microRNAs
miR-29c, miR-34a, miR-155, and miR-200b is associated with
strain-specific susceptibility to dietary nonalcoholic
steatohepatitis in mice. Lab Invest. 90:1437–1446. 2010. View Article : Google Scholar
|
|
31
|
Yu XF, Zou J, Bao ZJ and Dong J: miR-93
suppresses proliferation and colony formation of human colon cancer
stem cells. World J Gastroenterol. 17:4711–4717. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Abdeen SM and Olusi SO: Peptidyl arginine
deiminase: A novel immunohistochemical marker for liver fibrosis in
patients with chronic hepatitis. Acta Histochem. 112:592–603. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang MC, Chen CH, Liu HC, Chen CC, Ho CC
and Leu SJ: Differential patterns of serum brain-derived
neurotrophic factor levels in alcoholic patients with and without
delirium tremens during acute withdrawal. Alcohol Clin Exp Res.
35:126–131. 2011. View Article : Google Scholar
|
|
34
|
Choi SS, Sicklick JK, Ma Q, et al:
Sustained activation of Rac1 in hepatic stellate cells promotes
liver injury and fibrosis in mice. Hepatology. 44:1267–1277. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li X, Iomini C, Hyink D and Wilson PD:
PRKX critically regulates endothelial cell proliferation, migration
and vascular-like structure formation. Dev Biol. 356:475–485. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
De Lazzari F, Ravagnan P, Tenderini M, et
al: Circulating soluble-CD30 (sCD30) in patients with HCV-related
chronic hepatitis and in patients with alcoholic liver disease.
Hepatogastroenterology. 49:231–234. 2002.PubMed/NCBI
|
|
37
|
Desrivières S, Lourdusamy A, Müller C, et
al: Glucocorticoid receptor (NR3C1) gene polymorphisms and onset of
alcohol abuse in adolescents. Addict Biol. 16:510–513.
2011.PubMed/NCBI
|
|
38
|
Flatscher-Bader T, van der Brug M, Hwang
JW, et al: Alcohol-responsive genes in the frontal cortex and
nucleus accumbens of human alcoholics. J Neurochem. 93:359–370.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ding Z, Qian YB, Zhu LX and Xiong QR:
Promoter methylation and mRNA expression of DKK-3 and WIF-1 in
hepatocellular carcinoma. World J Gastroenterol. 15:2595–2601.
2009. View Article : Google Scholar : PubMed/NCBI
|
